Endonovo Announces Partnership with Former NFL Dallas Cowboy Defensive Lineman
Retrieved on:
木曜日, 4月 13, 2023
Concussion, Head Injuries, Falls, Brain damage, Harvard University, CTE, Pain, Alzheimer's disease, Patent, Patient, Central nervous system disease, Risk, Pain management, Sports Illustrated, Stroke, NFL, Interview, Post-traumatic stress disorder, Kansas City Chiefs, OTCQB, Injury, Hope, Brain, Research, TBI, MS, Athlete, Disorder, DSM-IV codes, Electromagnetic field, Addiction, FDA, Medical applications of radio frequency, PTSD, Safety, Post-concussion syndrome, History, Multiple sclerosis, Dallas, Swelling, PCS, Las Vegas Raiders, Therapy, Chronic traumatic encephalopathy, Partnership, PEMF, 2014 Kansas City Chiefs season, Inflammation, CNS, Central nervous system, National Football League, Traumatic brain injury, Health, Dallas Cowboys, Chronic pain, Dentistry, Medical imaging, Pharmaceutical industry
Endonovo aims to advance the use of PEMF therapy for PCS and TBI treatment and prevention through future medical studies.
Key Points:
- Endonovo aims to advance the use of PEMF therapy for PCS and TBI treatment and prevention through future medical studies.
- Endonovo’s partnership with former NFL defensive tackle, David Irving, will allow him to treat his joint injuries, chronic pain, Post-Concussion Syndrome and TBI symptoms through a use of SofPulse® PEMF devices.
- Through further research, Endonovo hopes to continue to advance the use of PEMF therapy for TBI treatment and prevention.
- With additional FDA clearance, Endonovo should be able to globally further impact the pain management market.